CLDI
CLDI
AMEX · Biotechnology

Calidi Biotherapeutics Inc

$0.86
+0.02 (+2.36%)
As of Feb 8, 2:31 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.75M 1.85M 1.56M
Net Income -488,923 -548,272 -518,591
EPS
Profit Margin -27.9% -29.7% -33.3%
Rev Growth +4.0% +6.5% +13.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.36M 2.38M 2.23M
Total Equity 2.58M 2.45M 2.67M
D/E Ratio 0.91 0.97 0.83
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -843,788 -899,520 -655,593
Free Cash Flow -343,922 -223,177 -234,743